Contact
Please use this form to send email to PR contact of this press release:
Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis
TO: